New Patients – Get 10% Off Your First Consultation with Code: NEW10 at Checkout

Circadin Melatonin

Melatonin tablets are indicated to supplement a hormone that is found naturally in our bodies. It is produced from the essential amino acid tryptophan, by transforming serotonin into melatonin in the pineal gland (which is at the base of the brain). Melatonin functions by resynchronizing an altered biological clock that is restoring not only the sleep rhythm but the rest of the circadian rhythms. In other words, a sleep disorder is reflecting an alteration of the biological clock and, therefore, the alteration of many other circadian rhythms. The recommended dose is one melatonin tablet (2 mg), taken orally after eating a meal, 1 or 2 hours before bedtime. This dose can be prolonged for a maximum of thirteen weeks. You must swallow the tablet whole. Melatonin tablets should not be crushed or halved.

Consult
Select
Checkout
01
Select

the items you wish
to order

02
Order reviewed

by our qualified
prescriber

03
Delivered

to your door step

Your Selection

Please use the options provided to make your final selection.

prodName
Circadin Melatonin
£29
Total
Consult
Select
Checkout
Please make a selection

Please note that whilst you are able to request the medicine strength and size required,
we will only be able to send on approval from our in house pharmacist.

Starts at £29.00
You’re almost there!

It is the prescribers duty to ensure that the medicine is being used safely and appropriately. please answer a few questions about yourself to help us process your request.

Confidentiality & Authenticity Assured

  • Fully Regulated UK Pharmacy
  • Authentic UK sourced medicines only.
  • Trading for more than 10 years.
  • Information Governance lead ensures all data is confidential

Need Help With Your Questionnaire?

Our customer service team is on hand Monday-Friday to help you with your queries.

Please call us on 08009788956 or
email us at: headoffice@pharmacyplanet.com

Price Comparison

Select your preferred options and see the best price

PackPrice (£)
-2mg10 tablets29.00
-2mg20 tablets38.00
-2mg30 Tablets45.00

It looks like you missed filling in questions from the last consultation.Click Here to submit your response.

  • No subscriptions or hidden fees

  • Secure checkout

  • UK Regulated online pharmacy

  • Trusted by over 250,000+ happy customers

Circadin Tablets 2mg (Melatonin) | Prescription Sleep Support for Disrupted Sleep Cycles

Circadin tablets contain melatonin 2mg in a prolonged-release formulation and are a prescription medicine used for the short-term treatment of primary insomnia in adults aged 55 and over. Melatonin is a naturally occurring hormone produced by the pineal gland in the brain that plays a central role in regulating the body’s internal clock and sleep-wake cycle. Disruption to this cycle, whether through age-related changes in melatonin production, shift patterns, or time zone changes during travel, can make it significantly harder to fall asleep or maintain restful sleep. Circadin is a Prescription Only Medicine and requires a clinical consultation with a registered prescriber before it can be supplied.

What Is Circadin?

Circadin is a prolonged-release melatonin tablet licensed in the UK for the short-term treatment of primary insomnia characterised by poor sleep quality in adults aged 55 years and over. It is manufactured by RAD Neurim Pharmaceuticals and contains melatonin 2mg per tablet in a prolonged-release formulation that is designed to mimic the natural pattern of melatonin secretion during the night.

Melatonin is not a sedative in the conventional pharmacological sense. It does not induce sleep in the way that benzodiazepines or z-drugs do. Instead, it works by supporting the body’s natural circadian rhythm, signalling to the brain that it is time to sleep and helping to consolidate the sleep-wake cycle.

Circadin is available as a Prescription Only Medicine and is only appropriate for patients who meet the licensed indication criteria. The prescriber will assess whether Circadin is suitable during the clinical consultation.

How Does Circadin Work?

Melatonin is produced naturally by the pineal gland in response to darkness. Its secretion rises in the evening as light levels fall, reaches a peak during the night, and declines in the early hours of the morning as daylight approaches. This pattern helps to signal to the body that it is time to sleep and plays a key role in maintaining a consistent sleep-wake cycle.

In older adults, natural melatonin production tends to decline with age. This reduction in the endogenous melatonin signal can contribute to difficulty falling asleep, reduced sleep quality, and disruption to the circadian rhythm. Circadin provides a low dose of exogenous melatonin in a prolonged-release format that slowly releases the hormone over the course of the night, supporting the body’s natural sleep cycle rather than inducing sedation directly.

The prolonged-release formulation is clinically important. It allows melatonin to be present at low, sustained levels throughout the night, which more closely resembles the physiological pattern of endogenous melatonin secretion than an immediate-release formulation would. This supports sleep maintenance as well as sleep onset.

How to Take Circadin

  • Take Circadin exactly as directed by your prescriber. Do not alter your dose or continue beyond the prescribed duration without speaking to your prescriber first.
  • Take one 2mg tablet by mouth once daily.
  • Take it two hours before your intended bedtime.
  • Swallow the tablet whole with a glass of water. Do not crush, split, or chew the tablet. The prolonged-release mechanism depends on the tablet remaining intact.
  • Take Circadin after food. Taking it with or after a meal helps to slow absorption slightly, which supports the prolonged-release profile.
  • Circadin is licensed for short-term use. The standard treatment duration is up to 13 weeks. Your prescriber will confirm the appropriate duration for your individual circumstances.
  • Avoid alcohol during treatment. Alcohol interferes with melatonin activity and may reduce the effectiveness of Circadin.
  • Avoid operating heavy machinery or driving after taking Circadin until you know how it affects you. Melatonin may cause drowsiness and impair alertness in some patients.
  • If you miss a dose, do not take it in the middle of the night or close to your waking time. Simply skip the missed dose and continue with your normal schedule the following evening.

Dosage and Strengths Available

Circadin 2mg Prolonged-Release Tablets
Circadin is available in a single strength of 2mg prolonged-release tablets.

For the short-term treatment of primary insomnia in adults aged 55 and over:
One 2mg tablet taken orally, once daily, two hours before bedtime, after food. The recommended treatment duration is up to 13 weeks.

There is currently one licensed strength of Circadin in the UK. The prolonged-release formulation distinguishes it from immediate-release melatonin products, which have a different absorption profile and are not licensed in the same way in the UK. Your prescriber will confirm whether Circadin is the appropriate formulation for your specific circumstances.

Side Effects and Safety Information

As with all medicines, Circadin can cause side effects, though not everyone will experience them. Circadin is generally considered to have a mild side effect profile compared to other prescription sleep medicines.

Common side effects (affecting up to 1 in 10 people) include:

  • Headache
  • Nasopharyngitis (runny nose or cold-like symptoms)
  • Back pain
  • Arthralgia (joint pain)

Less common side effects include:

  • Drowsiness or somnolence, particularly the morning after taking the tablet
  • Dizziness
  • Irritability or restlessness
  • Dry mouth
  • Nausea or abdominal discomfort
  • Hyperbilirubinaemia (elevated bilirubin levels)
  • Unusual dreams or nightmares
  • Migraine

Rare side effects include:

  • Angina pectoris
  • Palpitations
  • Hypertension
  • Visual disturbances
  • Vertigo
  • Decreased libido
  • Mood changes including tearfulness

If you experience any unexpected or concerning side effects, stop taking the medicine and contact your prescriber or pharmacist. Refer to the Patient Information Leaflet supplied with your medicine for a full list of possible side effects.

Important note on driving and operating machinery:

Circadin may cause drowsiness. Patients should not drive or operate heavy machinery after taking Circadin until they have established how the medicine affects them. This is particularly relevant for the first few days of treatment.

Who Can Take Circadin?

Circadin 2mg prolonged-release tablets are licensed for adults aged 55 years and over for the short-term treatment of primary insomnia.

Circadin should not be used by:

  • Adults under the age of 55. Circadin is not licensed for this age group for this indication.
  • Patients with known hypersensitivity to melatonin or any excipient in the formulation.
  • Patients with autoimmune diseases. Melatonin has immunomodulatory properties and its use in autoimmune conditions has not been fully characterised. Caution is advised and prescriber assessment is required.
  • Patients with severe hepatic impairment. Melatonin is metabolised by the liver. In severe hepatic disease, elevated plasma levels may occur and use is not recommended.

Caution is advised in:

  • Patients with renal impairment. Limited data are available on the use of Circadin in this group. Your prescriber will assess the appropriateness of treatment.
  • Patients taking fluvoxamine or other CYP1A2 inhibitors. These medicines can significantly increase melatonin plasma levels. Concurrent use should be avoided or used with caution under close prescriber supervision.
  • Patients taking quinolone antibiotics or cimetidine, which may also increase melatonin levels.
  • Patients taking benzodiazepines or other CNS depressants. Combined use may increase sedative effects.
  • Patients taking anticoagulants such as warfarin. There have been isolated reports of a possible interaction. Prescribers should be aware of this and monitor accordingly.
  • Patients with epilepsy. Melatonin may lower the seizure threshold in susceptible individuals. This should be discussed with a prescriber and, where relevant, a neurologist.
  • Patients who smoke. Smoking induces CYP1A2 and may reduce circulating melatonin levels, potentially reducing the effectiveness of Circadin.

Consultation and Prescribing Process

To obtain Circadin through Pharmacy Planet, you will need to complete a clinical consultation with one of our registered prescribers. The consultation is the primary step in this process. The prescribing of Circadin is a possible outcome of that consultation, not a guaranteed one.

During the consultation, the prescriber will review your age, medical history, current medicines, sleep history, and the nature of your sleep difficulties. They will assess whether Circadin is clinically appropriate for your specific circumstances, and whether you meet the licensed indication criteria for this medicine. A prescription will only be issued where the prescriber determines the medicine is suitable and safe for you.

If Circadin is not appropriate for your circumstances, the prescriber may suggest alternative approaches to sleep support, including sleep hygiene advice or referral to your GP for further assessment.

Storage and Handling

Store Circadin tablets below 25°C in a dry place, away from direct light and moisture. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging.

Return any unused or expired tablets to your pharmacy for safe disposal. Do not dispose of medicines via household waste or by flushing them down the drain.

Why Choose Pharmacy Planet?

Pharmacy Planet is a GPhC-registered online pharmacy providing access to a range of prescription and non-prescription medicines through a safe, regulated, and discreet service. All consultations are conducted by registered UK prescribers. Medicines are dispensed by our registered pharmacy team and dispatched in discreet packaging to protect your privacy.

We are committed to patient safety and always follow GPHC standards and ASA guidelines on the promotion of prescription medicines. If you have any questions about your medicine or your consultation, our pharmacy team is available to help.

References

Circadin Tablets 2mg (Melatonin) | Prescription Sleep Support for Disrupted Sleep Cycles

Circadin tablets contain melatonin 2mg in a prolonged-release formulation and are a prescription medicine used for the short-term treatment of primary insomnia in adults aged 55 and over. Melatonin is a naturally occurring hormone produced by the pineal gland in the brain that plays a central role in regulating the body’s internal clock and sleep-wake cycle. Disruption to this cycle, whether through age-related changes in melatonin production, shift patterns, or time zone changes during travel, can make it significantly harder to fall asleep or maintain restful sleep. Circadin is a Prescription Only Medicine and requires a clinical consultation with a registered prescriber before it can be supplied.

Circadin is a prolonged-release melatonin tablet licensed in the UK for the short-term treatment of primary insomnia characterised by poor sleep quality in adults aged 55 years and over. It is manufactured by RAD Neurim Pharmaceuticals and contains melatonin 2mg per tablet in a prolonged-release formulation that is designed to mimic the natural pattern of melatonin secretion during the night.

Melatonin is not a sedative in the conventional pharmacological sense. It does not induce sleep in the way that benzodiazepines or z-drugs do. Instead, it works by supporting the body’s natural circadian rhythm, signalling to the brain that it is time to sleep and helping to consolidate the sleep-wake cycle.

Circadin is available as a Prescription Only Medicine and is only appropriate for patients who meet the licensed indication criteria. The prescriber will assess whether Circadin is suitable during the clinical consultation.

Melatonin is produced naturally by the pineal gland in response to darkness. Its secretion rises in the evening as light levels fall, reaches a peak during the night, and declines in the early hours of the morning as daylight approaches. This pattern helps to signal to the body that it is time to sleep and plays a key role in maintaining a consistent sleep-wake cycle.

In older adults, natural melatonin production tends to decline with age. This reduction in the endogenous melatonin signal can contribute to difficulty falling asleep, reduced sleep quality, and disruption to the circadian rhythm. Circadin provides a low dose of exogenous melatonin in a prolonged-release format that slowly releases the hormone over the course of the night, supporting the body’s natural sleep cycle rather than inducing sedation directly.

The prolonged-release formulation is clinically important. It allows melatonin to be present at low, sustained levels throughout the night, which more closely resembles the physiological pattern of endogenous melatonin secretion than an immediate-release formulation would. This supports sleep maintenance as well as sleep onset.

  • Take Circadin exactly as directed by your prescriber. Do not alter your dose or continue beyond the prescribed duration without speaking to your prescriber first.
  • Take one 2mg tablet by mouth once daily.
  • Take it two hours before your intended bedtime.
  • Swallow the tablet whole with a glass of water. Do not crush, split, or chew the tablet. The prolonged-release mechanism depends on the tablet remaining intact.
  • Take Circadin after food. Taking it with or after a meal helps to slow absorption slightly, which supports the prolonged-release profile.
  • Circadin is licensed for short-term use. The standard treatment duration is up to 13 weeks. Your prescriber will confirm the appropriate duration for your individual circumstances.
  • Avoid alcohol during treatment. Alcohol interferes with melatonin activity and may reduce the effectiveness of Circadin.
  • Avoid operating heavy machinery or driving after taking Circadin until you know how it affects you. Melatonin may cause drowsiness and impair alertness in some patients.
  • If you miss a dose, do not take it in the middle of the night or close to your waking time. Simply skip the missed dose and continue with your normal schedule the following evening.

Circadin 2mg Prolonged-Release Tablets
Circadin is available in a single strength of 2mg prolonged-release tablets.

For the short-term treatment of primary insomnia in adults aged 55 and over:
One 2mg tablet taken orally, once daily, two hours before bedtime, after food. The recommended treatment duration is up to 13 weeks.

There is currently one licensed strength of Circadin in the UK. The prolonged-release formulation distinguishes it from immediate-release melatonin products, which have a different absorption profile and are not licensed in the same way in the UK. Your prescriber will confirm whether Circadin is the appropriate formulation for your specific circumstances.

As with all medicines, Circadin can cause side effects, though not everyone will experience them. Circadin is generally considered to have a mild side effect profile compared to other prescription sleep medicines.

Common side effects (affecting up to 1 in 10 people) include:

  • Headache
  • Nasopharyngitis (runny nose or cold-like symptoms)
  • Back pain
  • Arthralgia (joint pain)

Less common side effects include:

  • Drowsiness or somnolence, particularly the morning after taking the tablet
  • Dizziness
  • Irritability or restlessness
  • Dry mouth
  • Nausea or abdominal discomfort
  • Hyperbilirubinaemia (elevated bilirubin levels)
  • Unusual dreams or nightmares
  • Migraine

Rare side effects include:

  • Angina pectoris
  • Palpitations
  • Hypertension
  • Visual disturbances
  • Vertigo
  • Decreased libido
  • Mood changes including tearfulness

If you experience any unexpected or concerning side effects, stop taking the medicine and contact your prescriber or pharmacist. Refer to the Patient Information Leaflet supplied with your medicine for a full list of possible side effects.

Important note on driving and operating machinery:

Circadin may cause drowsiness. Patients should not drive or operate heavy machinery after taking Circadin until they have established how the medicine affects them. This is particularly relevant for the first few days of treatment.

Circadin 2mg prolonged-release tablets are licensed for adults aged 55 years and over for the short-term treatment of primary insomnia.

Circadin should not be used by:

  • Adults under the age of 55. Circadin is not licensed for this age group for this indication.
  • Patients with known hypersensitivity to melatonin or any excipient in the formulation.
  • Patients with autoimmune diseases. Melatonin has immunomodulatory properties and its use in autoimmune conditions has not been fully characterised. Caution is advised and prescriber assessment is required.
  • Patients with severe hepatic impairment. Melatonin is metabolised by the liver. In severe hepatic disease, elevated plasma levels may occur and use is not recommended.

Caution is advised in:

  • Patients with renal impairment. Limited data are available on the use of Circadin in this group. Your prescriber will assess the appropriateness of treatment.
  • Patients taking fluvoxamine or other CYP1A2 inhibitors. These medicines can significantly increase melatonin plasma levels. Concurrent use should be avoided or used with caution under close prescriber supervision.
  • Patients taking quinolone antibiotics or cimetidine, which may also increase melatonin levels.
  • Patients taking benzodiazepines or other CNS depressants. Combined use may increase sedative effects.
  • Patients taking anticoagulants such as warfarin. There have been isolated reports of a possible interaction. Prescribers should be aware of this and monitor accordingly.
  • Patients with epilepsy. Melatonin may lower the seizure threshold in susceptible individuals. This should be discussed with a prescriber and, where relevant, a neurologist.
  • Patients who smoke. Smoking induces CYP1A2 and may reduce circulating melatonin levels, potentially reducing the effectiveness of Circadin.

To obtain Circadin through Pharmacy Planet, you will need to complete a clinical consultation with one of our registered prescribers. The consultation is the primary step in this process. The prescribing of Circadin is a possible outcome of that consultation, not a guaranteed one.

During the consultation, the prescriber will review your age, medical history, current medicines, sleep history, and the nature of your sleep difficulties. They will assess whether Circadin is clinically appropriate for your specific circumstances, and whether you meet the licensed indication criteria for this medicine. A prescription will only be issued where the prescriber determines the medicine is suitable and safe for you.

If Circadin is not appropriate for your circumstances, the prescriber may suggest alternative approaches to sleep support, including sleep hygiene advice or referral to your GP for further assessment.

Store Circadin tablets below 25°C in a dry place, away from direct light and moisture. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging.

Return any unused or expired tablets to your pharmacy for safe disposal. Do not dispose of medicines via household waste or by flushing them down the drain.

Pharmacy Planet is a GPhC-registered online pharmacy providing access to a range of prescription and non-prescription medicines through a safe, regulated, and discreet service. All consultations are conducted by registered UK prescribers. Medicines are dispensed by our registered pharmacy team and dispatched in discreet packaging to protect your privacy.

We are committed to patient safety and always follow GPHC standards and ASA guidelines on the promotion of prescription medicines. If you have any questions about your medicine or your consultation, our pharmacy team is available to help.

Frequently Asked Questions

Circadin is a prescription prolonged-release melatonin tablet licensed in the UK for the short-term treatment of primary insomnia in adults aged 55 and over. It contains melatonin 2mg, a hormone that plays a key role in regulating the body's internal sleep-wake cycle. Circadin helps to support the natural melatonin signal that tends to decline with age, supporting sleep onset and quality. It is not a conventional sedative and works differently from other prescription sleep medicines. A prescription from a registered prescriber is required.

Circadin may not produce an immediate effect on the first night. It is designed to support and gradually reset the body's circadian rhythm rather than induce sedation rapidly. Some patients notice an improvement within the first week, while others may require a longer period of consistent use to notice a meaningful change in sleep quality. The licensed treatment duration is up to 13 weeks. If you have not noticed any benefit after several weeks, speak to your prescriber for a review.

No. Circadin 2mg is a prescription-only prolonged-release formulation of melatonin that is specifically licensed and regulated in the UK. Over-the-counter melatonin supplements sold in the UK are classified as food supplements, not medicines, and are not subject to the same clinical evidence requirements or regulatory standards as licensed medicines. Circadin's prolonged-release mechanism is designed to mimic the natural pattern of melatonin secretion during the night, which is clinically distinct from immediate-release formats. Your prescriber will confirm whether Circadin is the appropriate option for your circumstances.

No. Circadin 2mg prolonged-release tablets are licensed only for adults aged 55 and over for the short-term treatment of primary insomnia. It is not licensed for this indication in younger adults. If you are under 55 and experiencing sleep difficulties, speak to your GP, who can assess your situation and advise on appropriate management, which may include non-pharmacological approaches such as sleep hygiene advice or cognitive behavioural therapy for insomnia.

No. Alcohol should be avoided during treatment with Circadin. Alcohol interferes with melatonin activity and may reduce the effectiveness of the medicine. It can also increase the risk of drowsiness and next-morning sedation when combined with Circadin. Avoiding alcohol during your course of treatment supports the medicine working as intended and reduces the risk of side effects related to combined sedation.

Drowsiness or somnolence the morning after taking Circadin is listed as a less common side effect. Some patients do experience a degree of residual drowsiness, particularly in the early days of treatment. You should avoid driving or operating machinery until you have established how Circadin affects you. Taking it two hours before your intended bedtime, as directed, and after food helps to support the prolonged-release profile and reduce the likelihood of morning drowsiness. Speak to your prescriber if this is a persistent concern.

Some medicines can significantly increase melatonin plasma levels when taken alongside Circadin. Fluvoxamine, a CYP1A2 inhibitor, is the most clinically significant example and concurrent use should be avoided. Quinolone antibiotics and cimetidine may also raise melatonin levels. CNS depressants such as benzodiazepines may increase sedation. Patients taking warfarin should be monitored, as there are isolated reports of a possible interaction. Always provide your prescriber with a complete list of all current medicines, including supplements and over-the-counter products, before starting Circadin.

Circadin works by supplementing the body's natural melatonin signal to support the circadian rhythm and sleep-wake cycle. It is not a sedative and does not act on the same receptors as benzodiazepines or z-drugs such as zopiclone or zolpidem. It does not carry the same risk of dependence or tolerance that is associated with those medicines. It is specifically licensed for older adults, as declining melatonin production with age is a recognised contributor to primary insomnia in this group. Your prescriber will advise on the most appropriate treatment for your individual sleep difficulties.

Caution is advised. Melatonin has immunomodulatory properties, meaning it can interact with immune system activity. The use of Circadin in patients with autoimmune conditions has not been fully characterised in the SmPC and prescribers are advised to exercise caution. If you have an autoimmune condition, inform your prescriber during the consultation. They will assess whether Circadin is appropriate for you or whether an alternative approach to managing your sleep difficulties is more suitable.

Circadin is licensed for short-term use only, with a standard treatment duration of up to 13 weeks. Use beyond this period has not been fully established in the licensed evidence base. If you feel you need continued support with sleep after completing a course of Circadin, speak to your prescriber for a review. They will assess whether a further course is appropriate or whether other management strategies, including non-pharmacological approaches, should be considered for the longer term.

How it works
Start Consultation
Complete our online
clinical consultation

Answer a few questions on your health and your fitness goals.

Setup Coaching
Clinical
assessment

Our clinicians will review your clinical questionnaire to make sure treatment is right for you.

Ongoing Support
Welcome
aboard!

Once approved, you will access our wealth of experience and resources curated by our team and begin your clinical journey.

Start your journey with us

You’re almost there!

It is the prescribers duty to ensure that the medicine is being used safely and appropriately. please answer a few questions about yourself to help us process your request.

Confidentiality & Authenticity Assured

  • Fully Regulated UK Pharmacy
  • Authentic UK sourced medicines only.
  • Trading for more than 10 years.
  • Information Governance lead ensures all data is confidential

Need Help With Your Questionnaire?

Our customer service team is on hand Monday-Friday to help you with your queries.

Please call us on 08009788956 or
email us at: headoffice@pharmacyplanet.com

What our patients are saying

Need Help?

question mark
Do you have a question about weight loss treatment?

Start your weight loss journey heading in the right direction. Our team are here to help. Whether you’re unsure about which medicine is right for you or need help navigating the world of weight loss drugs, our team are on hand to help you make the right decision. We can put you in touch with one of our experienced weight loss clinicians so you can be sure you’re making the best decision with the most accurate information.

To get in touch, contact our Customer Service team on 0800 978 8956 or email headoffice@pharmacyplanet.com.

Meet the team
Pharmacist Image

Review By

GURDEV SEHMI

Last Updated On : Mar 13 2026

BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead

GPhC Number: 2050925

Pharmacist Image

Authored By

GURDEV SEHMI

Last Reviewed On : Mar 23 2026

BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead

GPhC Number: 2050925